Literature DB >> 20676804

Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma.

Bi Cheng Zhang1, Juan Gao, Jun Wang, Zhi Guo Rao, Bao Cheng Wang, Jian Fei Gao.   

Abstract

Tumor-associated macrophages (TAMs) have been implicated in promoting tumor progression. Nowadays, adenocarcinoma has surpassed squamous cell carcinoma as the most frequent type of lung cancer, but in lung adenocarcinoma, the correlation of TAMs with lymphangiogenesis patients remains unclear. The aim of this study was to examine the relationship between TAMs and lymphangiogenesis and the lung adenocarcinoma patients' prognosis. Tumor specimens from 65 patients with lung adenocarcinoma were determined for TAMs count and lymphatic microvessel density (LMVD) by immunohistochemistry. A positive correlation existed between TAMs count and D2-40-positive peritumoral LMVD (r=0.069, P<0.001). TAMs infiltration was significantly associated with P-TNM staging (P=0.042) and lymph node metastasis (P=0.037), and peritumoral LMVD was correlated with lymph node metastasis (P=0.003). A significant difference in overall survival was detected not only between tumors with a high TAMs count and a low TAMs count (P=0.009) but also between tumors with a high peritumoral LMVD and a low peritumoral LMVD (P=0.005). Both TAMs count and peritumoral LMVD were independent prognostic factors for overall survival. Our results indicate that TAMs infiltration correlates with tumor lymphangiogenesis and poor survival in lung adenocarcinoma.

Entities:  

Mesh:

Year:  2010        PMID: 20676804     DOI: 10.1007/s12032-010-9638-5

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  25 in total

Review 1.  The inflammatory tumor microenvironment and its impact on cancer development.

Authors:  Karin E de Visser; Lisa M Coussens
Journal:  Contrib Microbiol       Date:  2006

2.  Biochemical and functional characterization of three activated macrophage populations.

Authors:  Justin P Edwards; Xia Zhang; Kenneth A Frauwirth; David M Mosser
Journal:  J Leukoc Biol       Date:  2006-08-11       Impact factor: 4.962

Review 3.  Molecular pathways for lymphangiogenesis and their role in human disease.

Authors:  Steven A Stacker; Rae H Farnsworth; Tara Karnezis; Ramin Shayan; Darrin P Smith; Karri Paavonen; Natalia Davydova; Carol Caesar; Rachael Inder; Megan E Baldwin; Bradley K McColl; Sally Roufail; Richard A Williams; Richard A Hughes; Kari Alitalo; Marc G Achen
Journal:  Novartis Found Symp       Date:  2007

4.  Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer.

Authors:  Ferenc Renyi-Vamos; Jozsef Tovari; Janos Fillinger; Jozsef Timar; Sandor Paku; Istvan Kenessey; Gyula Ostoros; Laszlo Agocs; Ibolya Soltesz; Balazs Dome
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

Review 5.  Distinct role of macrophages in different tumor microenvironments.

Authors:  Claire E Lewis; Jeffrey W Pollard
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

6.  La mala educación of tumor-associated macrophages: Diverse pathways and new players.

Authors:  Alberto Mantovani
Journal:  Cancer Cell       Date:  2010-02-17       Impact factor: 31.743

7.  Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis.

Authors:  S J Mandriota; L Jussila; M Jeltsch; A Compagni; D Baetens; R Prevo; S Banerji; J Huarte; R Montesano; D G Jackson; L Orci; K Alitalo; G Christofori; M S Pepper
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

Review 8.  First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype.

Authors:  Marcello Tiseo; Marco Bartolotti; Francesco Gelsomino; Andrea Ardizzoni
Journal:  Expert Rev Anticancer Ther       Date:  2009-04       Impact factor: 4.512

9.  Prognostic significance of macrophage infiltration in leiomyosarcomas.

Authors:  Cheng-Han Lee; Inigo Espinosa; Suzan Vrijaldenhoven; Subbaya Subramanian; Kelli D Montgomery; Shirley Zhu; Robert J Marinelli; Johannes L Peterse; Neal Poulin; Torsten O Nielsen; Rob B West; C Blake Gilks; Matt van de Rijn
Journal:  Clin Cancer Res       Date:  2008-03-01       Impact factor: 12.531

10.  The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients.

Authors:  Kyuichi Kadota; Cheng-Long Huang; Dage Liu; Masaki Ueno; Yoshio Kushida; Reiji Haba; Hiroyasu Yokomise
Journal:  Eur J Cancer       Date:  2008-04-08       Impact factor: 9.162

View more
  54 in total

Review 1.  Macrophage-tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands.

Authors:  Thomas Schmidt; Isabel Ben-Batalla; Alexander Schultze; Sonja Loges
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

Review 2.  The secret ally: immunostimulation by anticancer drugs.

Authors:  Lorenzo Galluzzi; Laura Senovilla; Laurence Zitvogel; Guido Kroemer
Journal:  Nat Rev Drug Discov       Date:  2012-02-03       Impact factor: 84.694

3.  Origins of tumor-associated macrophages and neutrophils.

Authors:  Virna Cortez-Retamozo; Martin Etzrodt; Andita Newton; Philipp J Rauch; Aleksey Chudnovskiy; Cedric Berger; Russell J H Ryan; Yoshiko Iwamoto; Brett Marinelli; Rostic Gorbatov; Reza Forghani; Tatiana I Novobrantseva; Victor Koteliansky; Jose-Luiz Figueiredo; John W Chen; Daniel G Anderson; Matthias Nahrendorf; Filip K Swirski; Ralph Weissleder; Mikael J Pittet
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 4.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

5.  Therapeutically reeducating macrophages to treat GBM.

Authors:  Christopher Garris; Mikael J Pittet
Journal:  Nat Med       Date:  2013-10       Impact factor: 53.440

6.  Distribution and clinical significance of tumour-associated macrophages in pancreatic ductal adenocarcinoma: a retrospective analysis in China.

Authors:  S J Chen; Q B Zhang; L J Zeng; G D Lian; J J Li; C C Qian; Y Z Chen; Y T Chen; K H Huang
Journal:  Curr Oncol       Date:  2015-02       Impact factor: 3.677

7.  Positive correlation between PEDF expression levels and macrophage density in the human prostate.

Authors:  Thomas Nelius; Christina Samathanam; Dalia Martinez-Marin; Natalie Gaines; Jessica Stevens; Johnny Hickson; Werner de Riese; Stéphanie Filleur
Journal:  Prostate       Date:  2012-10-04       Impact factor: 4.104

Review 8.  Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers.

Authors:  Irina Larionova; Gulnara Tuguzbaeva; Anastasia Ponomaryova; Marina Stakheyeva; Nadezhda Cherdyntseva; Valentin Pavlov; Evgeniy Choinzonov; Julia Kzhyshkowska
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

9.  Angiotensin II drives the production of tumor-promoting macrophages.

Authors:  Virna Cortez-Retamozo; Martin Etzrodt; Andita Newton; Russell Ryan; Ferdinando Pucci; Selena W Sio; Wilson Kuswanto; Philipp J Rauch; Aleksey Chudnovskiy; Yoshiko Iwamoto; Rainer Kohler; Brett Marinelli; Rostic Gorbatov; Gregory Wojtkiewicz; Peter Panizzi; Mari Mino-Kenudson; Reza Forghani; Jose-Luiz Figueiredo; John W Chen; Ramnik Xavier; Filip K Swirski; Matthias Nahrendorf; Ralph Weissleder; Mikael J Pittet
Journal:  Immunity       Date:  2013-01-17       Impact factor: 31.745

10.  M2-polarized macrophages contribute to the decreased sensitivity of EGFR-TKIs treatment in patients with advanced lung adenocarcinoma.

Authors:  Bicheng Zhang; Yafei Zhang; Jie Zhao; Zhigang Wang; Tingting Wu; Wuling Ou; Jun Wang; Bo Yang; Yong Zhao; Zhiguo Rao; Jianfei Gao
Journal:  Med Oncol       Date:  2014-07-18       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.